Skip to content
Screener

Stryker SYK Return on equity

Discontinued — last reported Q4 '18

Return on equity at other companies

Baxter International logo
Baxter InternationalBAX
-16.7%-76.7pp
Johnson & Johnson logo
Johnson & JohnsonJNJ
25.7%-4.5pp
Axogen logo
AxogenAXGN
-18.2%-28.9pp
CONMED logo
CONMEDCNMD
5.5%-6.2pp
Merit Medical Systems logo
Merit Medical SystemsMMSI
9.1%0.0pp
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
-13.4%-4.6pp

Other financials

Income statement

See full
Revenue$6.6B+9.4%
Gross profit$4.5B+17.1%
Operating income$1.7B+49.1%
Net income$1.3B+44.3%
EPS (diluted)$3.30+44.1%

Balance sheet

See full
Cash & equivalents$3.4B+42.8%
Total debt$14.2B-15.2%
Total assets$47.9B+3.5%

Cash flow

See full
Operating cash flow$1.3B+13.5%
CapEx$202.0M+10.4%
Free cash flow$1.1B+14.1%

Valuation

See full
Market cap$124.86B-14.4%
Enterprise value$135.66B-15.3%
P/E33.5×-16.5×
P/S4.8×-1.3×

Profitability

See full
Gross margin65%+0.8pp
Operating margin21.4%+6.2pp
Net margin14.4%+2.2pp
FCF margin18.2%+1.3pp

Returns & leverage

See full
Debt / equity0.8×—
Current ratio2.2×+0.4×

Where this comes from

Calculated from Stryker’s reported figures.

net income/total stockholders equity=32.8%

Based on trailing twelve months.

The source filing: Stryker’s 10-K, filed February 6, 2020. Open the filing →

Filed
Feb 5, 2020, 7:00 PM EST
Fiscal year
FY2019
Accession
0000310764-20-000014

FAQ

What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.